SANA compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

SANASana Biotechnology, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

SANASana Biotechnology, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SANA 11

BEAMBeam Therapeutics, Inc. (Beam)supplier

—Flagship Pioneering Innovations V, Inc. (Flagship)unlistedsupplier

—FUJIFILM Cellular Dynamics, Inc. (FCDI)unlistedsupplier

—La Societe Pulsalys (Pulsalys)unlistedsupplier

7 more · SANA chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

SANASana Biotechnology, Inc.

2.56▼−5.88%· post 2.56

Mkt cap$769.4MRevenue—Revenue—

AMGNAmgen Inc

466.31▲+1.21%· post 466.40

ClosedOct 30 '26

Mkt cap$251.9BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

ClosedOct 30 '26

SANASana Biotechnology, Inc.

AMGNAmgen Inc

2.56▼−5.88%post 2.56

Price

466.31▲+1.21%post 466.40

$769.4M

Mkt cap

$251.9B

—

Revenue

$10.1BQ2 FY26

—

Revenue

$36.8BFY25

SANA2.56▼−5.88%vsAMGN466.31▲+1.21%ClosedOct 30 '26